Ziad F. Gellad, MD

Associate Professor of Medicine
Member in the Duke Clinical Research Institute
Campus mail 2301 Erwin Road, Duke North - DUMC 3703, Durham, NC 27710
Phone (919) 668-7802
Email address ziad.gellad@duke.edu

Dr. Gellad is an associate professor of medicine in the Division of Gastroenterology at Duke University Medical Center and a faculty member of the Duke Clinical Research Institute.  He is also a VA Career Development Awardee and holds an appointment in the Health Services Research and Development Center of Innovation at the Durham VA Medical Center.  His research focuses on the implementation of systems engineering methods to improve the quality and value of health care delivery with a specific emphasis in colorectal cancer screening.

Dr. Gellad has also received several innovation grants to develop and implement novel information technology platforms to improve the patient and clinician experience.  He is also an active contributor to the innovation and entrepreneurship activities within Duke University and co-founder of a health technology startup in Durham.

Dr. Gellad received his MD and MPH degrees from Johns Hopkins University.  He completed a residency in internal medicine and a fellowship in gastroenterology at Duke University Medical Center.  He is the Director of Quality for the Division of Gastroenterology and Associate vice Chair for Clinical Innovation in the Department of Medicine at Duke University Medical Center.   Dr. Gellad is past-chair of the Quality Measures Committee of the American Gastroenterological Association, associate editor for GI & Hepatology News and is on the Board of Editors for Clinical Gastroenterology and Hepatology.

In Their Words

Education and Training

  • Fellow in Gastroenterology, Medicine, Duke University, 2006 - 2009
  • Medical Resident, Medicine, Duke University, 2003 - 2006
  • M.D., Johns Hopkins University, 2003
  • M.P.H., Johns Hopkins University, 2002

Publications

Gellad, ZF, Muir, AJ, McHutchison, JG, Sievert, W, Sharara, AI, Brown, KA, Flisiak, R, Jacobson, IM, Kershenobich, D, Manns, MP, Schulman, KA, and Reed, SD. "Cost-effectiveness of truncated therapy for hepatitis C based on rapid virologic response." Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research 15, no. 6 (September 2012): 876-886.

PMID
22999138
Full Text

Gellad, ZF, Taheri, J, Burchfield, D, Cooper, K, Lothrop, S, and AL-Kawas, FH. "Discrete Event Simulation Modeling: A Valuable Tool to Optimize Endoscopy Unit Efficiency." April 2012.

Scholars@Duke

Gellad, ZF, Reed, SD, and Muir, AJ. "Economic evaluation of direct-acting antiviral therapy in chronic hepatitis C." Antiviral Therapy 17, no. 6 Pt B (January 2012): 1189-1199. (Review)

PMID
23186646
Full Text

Taheri, J, Gellad, Z, Burchfield, D, and Cooper, K. "A simulation study to reduce nurse overtime and improve patient flow time at a hospital endoscopy unit." Proceedings - Winter Simulation Conference (2012).

Full Text

Gellad, ZF, Naggie, S, Reed, SD, Clark, PJ, Thompson, AJ, Schulman, KA, and Muir, AJ. "THE COST-EFFECTIVENESS OF A TELAPREVIR-INCLUSIVE REGIMEN AS INITIAL THERAPY FOR GENOTYPE 1 HEPATITIS C INFECTION IN INDIVIDUALS WITH THE CC IL-28B POLYMORPHISM." October 2011.

Scholars@Duke

Gellad, ZF, Stechuchak, KM, Fisher, DA, Olsen, MK, McDuffie, JR, Ostbye, T, and Yancy, WS. "Longitudinal adherence to fecal occult blood testing impacts colorectal cancer screening quality." The American Journal of Gastroenterology 106, no. 6 (June 2011): 1125-1134.

PMID
21304501
Full Text

Gellad, ZF, Reed, S, Muir, AJ, McHutchison, J, Steven, W, Sharara, AI, Brown, KAA, Flisiak, R, Jacobson, IM, Kershenobich, D, Manns, MP, and Schulman, KA. "Truncated Therapy Based on Rapid Virologic Response is a Cost Effective Treatment Paradigm for Chronic Hepatitis C." May 2011.

Scholars@Duke

Gellad, ZF, and Provenzale, D. "Reply." Gastroenterology 139, no. 3 (September 2010): 1065-1065.

Full Text

Gellad, ZF, Weiss, DG, Ahnen, DJ, Lieberman, DA, Jackson, GL, and Provenzale, D. "Colonoscopy withdrawal time and risk of neoplasia at 5 years: results from VA Cooperative Studies Program 380." Am J Gastroenterol 105, no. 8 (August 2010): 1746-1752.

PMID
20234348
Full Text

Jackson, GL, Melton, LD, Abbott, DH, Zullig, LL, Ordin, DL, Grambow, SC, Hamilton, NS, Zafar, SY, Gellad, ZF, Kelley, MJ, and Provenzale, D. "Quality of nonmetastatic colorectal cancer care in the Department of Veterans Affairs." Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology 28, no. 19 (July 2010): 3176-3181.

PMID
20516431
Full Text

Pages